NDC 21695-665

Plavix

Clopidogrel Bisulfate

Plavix is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Clopidogrel Bisulfate.

Product ID21695-665_1086a7b4-b89b-4bee-8120-5f752626c046
NDC21695-665
Product TypeHuman Prescription Drug
Proprietary NamePlavix
Generic NameClopidogrel Bisulfate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date1900-01-01
Marketing CategoryNDA / NDA
Application NumberNDA020839
Labeler NameRebel Distributors Corp
Substance NameCLOPIDOGREL BISULFATE
Active Ingredient Strength75 mg/1
Pharm ClassesDecreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-665-90

90 TABLET, FILM COATED in 1 BOTTLE (21695-665-90)
Marketing Start Date1900-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-665-90 [21695066590]

Plavix TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020839
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1900-01-01
Inactivation Date2019-09-24

NDC 21695-665-30 [21695066530]

Plavix TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020839
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1900-01-01
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
CLOPIDOGREL BISULFATE75 mg/1

OpenFDA Data

SPL SET ID:1086a7b4-b89b-4bee-8120-5f752626c046
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213169
  • 309362
  • Pharmacological Class

    • Decreased Platelet Aggregation [PE]
    • P2Y12 Platelet Inhibitor [EPC]
    • P2Y12 Receptor Antagonists [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]

    NDC Crossover Matching brand name "Plavix" or generic name "Clopidogrel Bisulfate"

    NDCBrand NameGeneric Name
    0024-1171Plavixclopidogrel
    0024-1332Plavixclopidogrel
    21695-665Plavixclopidogrel bisulfate
    53808-0763PlavixPlavix
    55289-911PlavixPlavix
    63653-1332PlavixPlavix
    63653-1171PlavixPlavix
    67046-604PlavixPlavix
    0615-8014Clopidogrelclopidogrel bisulfate
    0904-6467Clopidogrelclopidogrel bisulfate
    33261-987ClopidogrelClopidogrel Bisulfate
    50090-1301Clopidogrelclopidogrel bisulfate
    50090-2082ClopidogrelClopidogrel Bisulfate
    0904-6294Clopidogrel BisulfateClopidogrel Bisulfate
    13668-141Clopidogrel BisulfateClopidogrel Bisulfate
    43063-371Clopidogrel BisulfateClopidogrel Bisulfate
    43353-269clopidogrel bisulfateclopidogrel bisulfate
    47335-894Clopidogrel BisulfateClopidogrel Bisulfate
    50090-1300Clopidogrel BisulfateClopidogrel Bisulfate

    Trademark Results [Plavix]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PLAVIX
    PLAVIX
    90168789 not registered Live/Pending
    Sanofi
    2020-09-09
    PLAVIX
    PLAVIX
    75443638 2320230 Live/Registered
    SANOFI
    1998-03-03
    PLAVIX
    PLAVIX
    75438881 2380297 Live/Registered
    SANOFI
    1998-02-23
    PLAVIX
    PLAVIX
    74482767 2042583 Live/Registered
    SANOFI
    1994-01-26

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.